MichaelBenjaminDavidsonDOFACE(He/Him)
Endocrinology • Indianapolis, INDiabetes
Executive Director - Medical, Eli Lilly and Company
Dr. Davidson is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
893 Delaware St
Indianapolis, IN 46285Phone+1 603-312-6893
Summary
- Michael Davidson, DO, is an endocrinologist, with a specialization in diabetes, especially type I diabetes. His medical education includes a degree from University of New England College of Osteopathic Medicine, and a residency and fellowship at Cleveland Clinic Foundation between 2002 - 2007. He's an experienced practitioner who has worked with Wentworth Health Partners and is currently the Medical Director at Eli Lilly Corporate Center since 2022. Dr. Davidson has several high-impact publications in the field of endocrinology and has received recognition such as CMS Meaningful Use Stage 1 Certification and fellowship from the American Association of Clinical Endocrinology.
Education & Training
Cleveland Clinic FoundationFellowship, Endocrinology, Diabetes, and Metabolism, 2007- Cleveland Clinic FoundationResidency, Internal Medicine, 2005
- Cleveland Clinic2002 - 2003
University of New England College of Osteopathic MedicineClass of 2002
Certifications & Licensure
NH State License 2007 - 2023
OH State License 2002 - 2009- American Board of Internal Medicine Endocrinology, Diabetes and Metabolism
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification NextGen Ambulatory EHR, NextGen Healthcare, 2012-2013
- Fellow (FACE) American Association of Clinical Endocrinology
Publications & Presentations
PubMed
- 165 citationsAACE/ACE comprehensive diabetes management algorithm 2015.Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden
Endocrine Practice. 2015-05-01 - 309 citationsAACE comprehensive diabetes management algorithm 2013.Alan J. Garber, Martin J. Abrahamson, Joshua I. Barzilay, Lawrence Blonde, Zachary T. Bloomgarden
Endocrine Practice. 2013-04-18 - 59 citationsDiabetic cardiomyocyte dysfunction and myocyte insulin resistance: role of glucose-induced PKC activity.Amy J. Davidoff, Michael B. Davidson, Marybeth W. Carmody, Mari-Elena Davis, Jun Ren
Molecular and Cellular Biochemistry. 2004-07-01
Committees
- member, AACE/ACE COMPREHENSIVE DIABETES MANAGEMENT ALGORITHM 2015 2013 - 2015
Professional Memberships
- Member
- Member
- Endocrine SocietyMember
- Member
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
